Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers

Rebouissou et al. recently provided preclinical evidence that a subset of patients with muscle-invasive bladder cancer might benefit from anti-epidermal growth factor receptor (EGFR) therapy and reported diagnostic tools for identifying these patients in the clinical setting. This work also identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebret, Thierry, Neuzillet, Yann, Houede, Nadine, Rebouissou, Sandra, Bernard-Pierrot, Isabelle, De Reynies, Aurélien, Benhamou, Simone, Allory, Yves, Radvanyi, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905367/
https://www.ncbi.nlm.nih.gov/pubmed/27308521
http://dx.doi.org/10.1080/23723556.2014.999507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905367/
https://www.ncbi.nlm.nih.gov/pubmed/27308521
http://dx.doi.org/10.1080/23723556.2014.999507

Ejemplares similares